Opendata, web and dolomites
H2020 projects about "pancreatic"
The page lists 98 projects related to the topic "pancreatic".
| # | |||
|---|---|---|---|
| 1 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 2 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 3 | TheLiRep | Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes | 2015 |
| 4 | BALaNCE | BreAking the Link betweeN myo10 and CancEr | 2015 |
| 5 | MyCyFAPP | Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool. | 2015 |
| 6 | PRECEDE | PRECEDE: PancREatic Cancer Early DEtection | 2014 |
| 7 | FIBERSTAR | FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency | 2016 |
| 8 | GLUCOTOX | Does reducing β-cell glucotoxicity increase the hyperglycaemia-lowering effect of physical exercise in type 2 diabetes? | 2015 |
| 9 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 10 | Beta-splicenet | ALTERNATIVE SPLICING NETWORKS IN PANCREATIC BETA CELLS | 2015 |
| 11 | EDePDAC | Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA | 2015 |
| 12 | DRIVE | Diabetes Reversing Implants with enhanced Viability and long-term Efficacy | 2015 |
| 13 | BIOCAPAN | BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy | 2015 |
| 14 | IMMPACT | Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer. | 2015 |
| 15 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 16 | BetaCellTherapy | Beta Cell Generation by Stem Cell-Derived Implants in Diabetes | 2015 |
| 17 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 18 | T2DSystems | Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes | 2016 |
| 19 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 20 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 21 | HONEYDIAB-8 | Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes | 2016 |
| 22 | AB-Prevention | Highly efficient and eco-innovative probiotic food supplement for antibiotic-associated disorders prevention | 2016 |
| 23 | ZPR | The Pancreas Regulome: From causality to prediction of non-coding mutations in human pancreatic diseases | 2016 |
| 24 | TSGPs-of-CFSs | Role of Tumour Suppressor Gene Products of Common Fragile Sites in Human Diseases | 2016 |
| 25 | NANOBreg | A new therapeutic platform based on nanotechnology to promote T- and B-regulatory networks | 2016 |
| 26 | OPTIMIsE | Commercial feasibility of the Novio-PlainGel: a novel synthetic, reversible thermosensitive, biomimetic hydrogel for organoid-based precision medicine | 2016 |
| 27 | INTEGRATE | Central integration of metabolic and hedonic cues in metabolic health | 2016 |
| 28 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 29 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 30 | BETASCREEN | A Unique Pancreatic Human Beta Cells to revolutionize the Diabetes Drug Discovery | 2016 |
| 31 | MATRICAN | Matrix during cancer progression | 2016 |
| 32 | ORCHESTRATE | Building complex life through self-organization: from organ to organism | 2016 |
| 33 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 34 | MILEAGE | Microelements in Life Expectancy and Aging | 2017 |
| 35 | TISuMR | Integrated Tissue Slice Culture and NMR Metabolomics – A Novel Approach Towards SystemicUnderstanding of Liver Function And Disease | 2017 |
| 36 | BETA-BACT | Beta-cell inflammation and dysfunction induced by bacterial translocation | 2016 |
| 37 | DAMOC | Diabetes Approach by Multi-Organ-on-a-Chip | 2017 |
| 38 | Reg-Seq | Functional genomics of non-coding mutations in regulatory regions of four metabolic tissues, and their involvement into type 2 diabetes through large-scale sequencing | 2017 |
| 39 | BETASCREEN | Validation of an in vivo translational medicine approach for the treatment of diabetes and diabetes complications | 2017 |
| 40 | ZINCLAPS | Light-addressable potentiometric sensors (LAPS) for zinc imaging with high spatiotemporal resolution for elucidating the role of zinc in age related macular degeneration. | 2017 |
| 41 | ExoSensor | A Nano-photoelectric Exosome Biosensor for Point-of-care Diagnosis of Early-stage Cancer | 2017 |
| 42 | DrugSearchTool | Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target | 2018 |
| 43 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 44 | CTC4BMP | Circulating tumor cells for tailoring BMP targeted therapies | 2017 |
| 45 | BioProbe-PIT | Local molecular profiling of tumor tissue sections: towards personalized immunotherapy | 2017 |
| 46 | PAINTBOX | Pancreatic islet dysfunction and type 2 diabetes – beyond the genome | 2017 |
| 47 | ARMOR-T | Armoring multifunctional T cells for cancer therapy | 2018 |
| 48 | iNanoBIT | Integration of Nano- and Biotechnology for beta-cell and islet Transplantation | 2017 |
| 49 | CESYDE | Ceramide Synthases in Diabetic Beta Cell Demise | 2018 |
| 50 | Io-EMP | Tissue-derived acellular micro-scaffold technology reducing or eliminating diabetics’ dependence oninsulin therapy | 2017 |
| 51 | DiSect | The Tumour Stroma as a Driver of Clonal Selection | 2018 |
| 52 | ExoSonic | A microfluidic chip for non-invasive, early detection of pancreatic cancer – liquid biopsy | 2018 |
| 53 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 54 | LASER OPTIMAL | Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL | 2018 |
| 55 | Reprogram-Diabetes | In vivo drug discovery for cellular reprogramming to β-cells – towards a future regenerative therapy for diabetes | 2018 |
| 56 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 57 | IMPACT-HEALTH | IMaging Pancreatic Alpha-cells Calcium Tied with HEterogeneous Analysis of Labeled Transcription factors with in situ Hybridization | 2018 |
| 58 | INSULYSOSOME | The role of CD63 in lysosomal degradation of insulin granules in pancreatic beta cells in T2D diabetes | 2018 |
| 59 | NanoBioNext | Nanoscale Biomeasurements of Nerve Cells and Vesicles: Molecular Substructure and the Nature of Exocytosis | 2018 |
| 60 | pBioStrat-for-PDA | Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 |
| 61 | Pan3DP | 3D bioprinting of pancreatic tissue for biomedical research | 2018 |
| 62 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 63 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 64 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
| 65 | DELIVER | DELIVERy of advanced therapies for diabetes training network | 2019 |
| 66 | pHioniC | pH and Ion Transport in Pancreatic Cancer | 2018 |
| 67 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 68 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 69 | SiMBiT | Single molecule bio-electronic smart system array for clinical testing | 2019 |
| 70 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 71 | DecodeDiabetes | Expanding the genetic etiological and diagnostic spectrum of monogenic diabetes mellitus | 2018 |
| 72 | PACA-MET | Genome-wide surveys and functional analysis of pancreatic cancer metastasis drivers | 2019 |
| 73 | GOLIATH | Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds | 2019 |
| 74 | RGD-Diabetes | Development of RGD-therapeutics for cardio-metabolic disease | 2019 |
| 75 | CentrosoTME | The role of extra centrosomes on the tumour microenvironment | 2019 |
| 76 | PanILC | Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia | 2019 |
| 77 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 78 | MultiPan | A Multi-omics Approach To Decode Epigenetic Lesions In Pancreatic Cancer Development | 2019 |
| 79 | EYELETS | A regenerative medicine approach in diabetes. | 2020 |
| 80 | MADMpancreas | Using the precision mouse genetic tool MADM to elucidate the role of EGFR in directing beta cell differentiation and pancreatic morphogenesis | 2019 |
| 81 | ePANC-SPLICE | Regulation and Function of Endocrine-Specific Splicing Programs in Pancreas and their Role in Diabetes | 2020 |
| 82 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 83 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 84 | VISION | Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers | 2019 |
| 85 | ENDOGI | The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis | 2019 |
| 86 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
| 87 | PRECODE | PancREatic Cancer OrganoiDs rEsearch Network | 2019 |
| 88 | BLOC | BENCHTOP NMR FOR LAB-ON-CHIP | 2020 |
| 89 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 90 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 91 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 92 | ESPACE | Human Cell Atlas of the Pancreas | 2020 |
| 93 | ISLET | Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe | 2020 |
| 94 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 95 | SPOT | SPOT - Synthesis of Pretargeted Oncology Theranostics | 2020 |
| 96 | PDASwITch | Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer | 2020 |
| 97 | DIM-CrIC | Decreasing Pancreatic Adenocarcinoma-related Inflammation using small molecule inhibitors of STING | 2020 |
| 98 | OPEN P-CAN | Dissecting the role of mitochondrial dynamics in pancreatic carcinogenesis | 2020 |